CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 10 enrolled
Drug / intervention
doxycycline +1 moredrug
Likely dose
doxycycline 200mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01788215
NCT01788215Phase 3Completed
CompareCT.gov

The Use of an MMP Inhibitor, Doxycycline, to Reduce Ovarian Androgen Production and Restore Normal Cycling in Women With Polycystic Ovarian Syndrome

University of Rochester·interventional·Posted Feb 11, 2013·Updated Jan 13, 2016

In Brief

A Phase 3 clinical trial evaluating doxycycline and Sugar Pill for Polycystic Ovarian Syndrome (PCOS) and 2 related conditions. Completed, enrolled 10 participants across 1 site.

Detailed Summary

The purpose of this study is to study the effect of a commonly used antibiotic, doxycycline, on the production of ovarian hormones and menstrual cycles in women with Polycystic Ovarian Syndrome (PCOS).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPolycystic Ovarian Syndrome (PCOS), Irregular Menstrual Cycles, Androgen Excess
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 11, 2013
Enrollment StartNov 1, 2010
Primary CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 13.4 years ago

Interventions

doxycyclinedrug

200mg/day in divided doses of 100mg twice daily

Sugar Pillother

1 pill twice a day